GLP-1 medications
The latest news about GLP-1 medications: headlines, AI summaries and the full story from every source.
- FDA Mandates Safety Warnings for GLP-1 Drugs Over Potential Vision Loss Risk
- Novonesis Explores Microbiome Supplements to Complement GLP-1 Weight-Loss Treatments
- AbbVie Reports Improved Facial Satisfaction Among GLP-1 Weight-Loss Medication Users
- McKesson Reports Strong Q2 2027 Results Driven by GLP-1 Growth and Raises Fiscal Guidance
- Employers Weigh Costs and Benefits of GLP-1 Medication Coverage
- Walgreens Expands Weight Management Services with New GLP-1 Support and Virtual Care
- GLP-1 Medication Users Face Financial Trade-offs Between Health Costs and Retirement Savings
- OAC Urges Cigna to Reconsider Decision on GLP-1 Medication Coverage for Weight Management
- Viking Therapeutics Shares Rise Over 30% on Encouraging Weight-Loss Drug Trial Results
- Novo Nordisk's Oral Wegovy Shows Greatest Weight Loss in Patients with Recent Weight Gain
- Eli Lilly CEO Highlights Growing Market Share for Foundayo Oral GLP-1 Medication
- Eli Lilly CEO Highlights Growth Drivers for Obesity Drug Market
- Berenberg Upgrades Eli Lilly Amid Strong Performance of GLP-1 Drugs
- Costco Expands Pharmacy and Prescription Services
- Pfizer Acquires Weight-Loss Biotech to Strengthen Pipeline in Growing Market
- New GLP-1 Weight Loss Pills May Strain Employer Insurance Coverage Due to Rising Costs
- CVS Health Announces Expansion into GLP-1 Weight-Loss Medication Services
- Eli Lilly's Obesity Drug Sales Face Medicare Access Test
- CVS Health Announces Coverage of Eli Lilly's Weight Management Medicines
- Costco Reports Strong Q3 Fiscal 2026 Sales Growth Driven by Protein Product Demand
- Lilly's Obesity Medicines Gaining Wider Insurance Coverage in the U.S.
- Medicare GLP-1 Coverage Expansion Delayed Indefinitely